UnitedHealth/$UNH
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About UnitedHealth
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Ticker
$UNH
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
400,000
ISIN
US91324P1021
Website
UnitedHealth Metrics
BasicAdvanced
$275B
12.70
$23.82
0.57
$8.51
2.92%
Price and volume
Market cap
$275B
Beta
0.57
52-week high
$613.92
52-week low
$248.88
Average daily volume
24M
Dividend rate
$8.51
Financial strength
Current ratio
0.849
Quick ratio
0.54
Long term debt to equity
67.781
Total debt to equity
77.277
Dividend payout ratio (TTM)
34.90%
Interest coverage (TTM)
8.25%
Profitability
EBITDA (TTM)
36,238
Gross margin (TTM)
21.99%
Net profit margin (TTM)
5.39%
Operating margin (TTM)
8.16%
Effective tax rate (TTM)
18.59%
Revenue per employee (TTM)
$1,030,000
Management effectiveness
Return on assets (TTM)
7.04%
Return on equity (TTM)
22.70%
Valuation
Price to earnings (TTM)
12.703
Price to revenue (TTM)
0.679
Price to book
2.76
Price to tangible book (TTM)
-7.76
Price to free cash flow (TTM)
11.18
Free cash flow yield (TTM)
8.94%
Free cash flow per share (TTM)
2,706.80%
Dividend yield (TTM)
2.81%
Forward dividend yield
2.92%
Growth
Revenue change (TTM)
8.06%
Earnings per share change (TTM)
44.68%
3-year revenue growth (CAGR)
11.28%
10-year revenue growth (CAGR)
11.79%
3-year earnings per share growth (CAGR)
9.25%
10-year earnings per share growth (CAGR)
14.66%
3-year dividend per share growth (CAGR)
13.14%
10-year dividend per share growth (CAGR)
18.80%
What the Analysts think about UnitedHealth
Analyst ratings (Buy, Hold, Sell) for UnitedHealth stock.
Bulls say / Bears say
UnitedHealth Group's Optum segment is experiencing strong performance, with Optum Rx having a robust selling season, securing new wins and maintaining high customer retention, underscoring the value of pharmacy benefit managers in reducing drug prices. (TipRanks)
The company has a forward P/E ratio of 11.31, indicating a promising valuation relative to future earnings, coupled with a return on equity of 22.70%, showcasing efficient management and profitability. (DirectorsTalk Interviews)
UnitedHealth Group has been increasing its dividend for 15 consecutive years, with a current yield of 2.83% and a payout ratio of 35.18%, reflecting a commitment to returning value to shareholders. (MarketBeat)
UnitedHealth Group has faced a series of crises, including the assassination of a senior executive, investigations for Medicare Advantage fraud, and a massive cyberattack compromising data of over 190 million people, leading to a 53% stock price decline over six months. (Cinco Días)
The company experienced an unexpected spike in care usage among Medicare Advantage enrollees during the first quarter, leading to a significant reduction in its 2025 earnings forecast and the worst single-day stock drop in over 25 years. (AP News)
UnitedHealth Group is planning to exit Latin America through a potential $1 billion sale of its Banmedica subsidiary, following substantial losses and an $8.3 billion write-down from previous divestitures, indicating challenges in its international operations. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 23 Jun 2025.
UnitedHealth Financial Performance
Revenues and expenses
UnitedHealth Earnings Performance
Company profitability
UnitedHealth News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for UnitedHealth stock?
UnitedHealth (UNH) has a market cap of $275B as of June 27, 2025.
What is the P/E ratio for UnitedHealth stock?
The price to earnings (P/E) ratio for UnitedHealth (UNH) stock is 12.7 as of June 27, 2025.
Does UnitedHealth stock pay dividends?
Yes, the UnitedHealth (UNH) stock pays dividends to shareholders. As of June 27, 2025, the dividend rate is $8.51 and the yield is 2.92%. UnitedHealth has a payout ratio of 34.9% on a trailing twelve-month basis.
When is the next UnitedHealth dividend payment date?
The next UnitedHealth (UNH) dividend payment date is unconfirmed.
What is the beta indicator for UnitedHealth?
UnitedHealth (UNH) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.